2022-12-01 09875632 2023-11-30 09875632 2022-12-01 2023-11-30 09875632 2022-11-30 09875632 2021-12-01 2022-11-30 09875632 uk-core:WithinOneYear 2022-11-30 09875632 uk-core:WithinOneYear 2023-11-30 09875632 uk-core:ShareCapital 2023-11-30 09875632 uk-core:ShareCapital 2022-11-30 09875632 uk-core:RetainedEarningsAccumulatedLosses 2023-11-30 09875632 uk-core:RetainedEarningsAccumulatedLosses 2022-11-30 09875632 uk-core:OtherMiscellaneousReserve 2023-11-30 09875632 uk-bus:Director1 2022-12-01 2023-11-30 09875632 uk-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-11-30 09875632 uk-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-12-01 2023-11-30 09875632 uk-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-11-30 iso4217:GBP xbrli:pure 09875632 uk-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 09875632 uk-bus:FRS102 2022-12-01 2023-11-30 09875632 uk-bus:FilletedAccounts 2022-12-01 2023-11-30 09875632 uk-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30
Esquare Lab Limited
Registered Number:09875632
For the year ended 30 November 2023
England and Wales
Unaudited Financial Statements
2
For the year ended 30 November 2023
Esquare Lab Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
09875632
As at 30 November 2023
Esquare Lab Limited
Statement of Financial Position
£
£
2022
2023
Notes
Fixed assets
Intangible assets
177,819
160,473
2
177,819
160,473
Current assets
Trade and other receivables
21
15
3
51,116
Cash and cash equivalents
29,072
29,087
51,137
Trade and other payables: amounts falling due within one
year
(51,177)
(53,673)
4
(40)
(24,586)
Net current liabilities
Total assets less current liabilities
153,233
160,433
153,233
Net assets
160,433
Capital and reserves
Called up share capital
106
106
Retained earnings
(28,279)
(21,079)
Other reserves
181,406
181,406
153,233
160,433
Shareholders' funds
For the year ended 30 November 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Vincenzo Navanteri Director
These financial statements were approved and authorised for issue by the Board on 23 July 2024 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 30 November 2023
Esquare Lab Limited
Notes to the Financial Statements
Statutory Information
Esquare Lab Limited is a private limited company, limited by shares, domiciled in England and Wales, registration
number 09875632.
Registered address:
C/O Kevad Ltd, Office 22
The Joiners Shop, The Historic Dockyard
Chatham
Kent
ME4 4TZ
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate at the date of transaction. Exchange rate differences are taken into account in arriving at the operating result.
Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the
extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.
Trade and other creditors
Trade and other creditors are measured at their transaction price unless the arrangement constitutes a financing
transaction in which case the transaction is measured at present value of future payments discounted at prevailing
market rate of interest. Other financial liabilities are initially measured at fair value net of their transaction costs. They
are subsequently measured at amortised cost using the effective interest method.
2. Intangible fixed assets
Research &
Development
Cost or valuation
£
At 01 December 2022
160,473
Additions
17,346
At 30 November 2023
177,819
2 of 3
5
For the year ended 30 November 2023
Esquare Lab Limited
Notes to the Financial Statements Continued
3. Trade and other receivables
2022
2023
£
£
Other debtors
15
21
4. Trade and other payables: amounts falling due within one year
2022
2023
£
£
Trade creditors
3,269
773
Other creditors
50,404
50,404
53,673
51,177
5. Average number of persons employed
During the year the average number of employees and directors was 1 (2022 : 1)
3 of 3